Cipla US unit recalls 6 batches of Albuterol sulfate inhalation aerosol over container defect Ruchika Sharma7 July 2023 11:26 AM ISTCipla said there were no adverse events reported for the inhaler related to the recall.
Dr Peter Mugyenyi resigns as Independent Director of Cipla Ruchika Sharma15 May 2023 12:27 PM ISTMumbai: Through a recent BSE filing, Cipla has announced that Dr Peter Mugyenyi, Independent Director of the Company has resigned from the position of...
Cipla net profit up 45 percent at Rs 526 crore in Q4 Ruchika Sharma13 May 2023 11:44 AM ISTTotal revenue rose to Rs 22,753 crore last fiscal as against Rs 21,763 crore in 2021-22 fiscal.
Cipla arm gets zero Form 483 observations from USFDA for USA facility Ruchika Sharma3 May 2023 12:30 PM ISTMumbai: Cipla has recently announced that the US Food and Drug Administration has concluded inspection with zero Form 483 observations at the Fall...
Cipla joins hands with Novartis Pharma AG to market diabetes drug Galvus in India Ruchika Sharma10 April 2023 3:10 PM ISTGalvus is one of the leading brands in the Dipeptidyl Peptidase-4 (DPP4) space and amongst the prominent brands in the oral diabetic medication...
Cipla to sell 51 percent stake in Uganda arm for USD 25-30 million Ruchika Sharma15 March 2023 4:00 PM ISTMumbai: Pharma major Cipla Limited and its wholly owned subsidiaries, Cipla (EU) Limited, UK and Meditab Holdings Limited, Mauritius, have entered...
USFDA inspection: Cipla gets 8 observations for Pithampur facility Ruchika Sharma20 Feb 2023 12:15 PM ISTMumbai: Cipla has recently announced that the United States Food and Drug Administration (USFDA) has issued 8 inspectional observations in Form 483...
Cipla net profit rises 7 percent to Rs 808 crore in Q3 Ruchika Sharma28 Jan 2023 10:15 AM ISTNew Delhi: Drug major Cipla on Wednesday reported a 7 percent increase in its consolidated net profit to Rs 808 crore for the third quarter ended...
Cipla UK subsidiary to infuse EUR 15 million in Ethris Ruchika Sharma30 Dec 2022 11:32 AM ISTMumbai: Cipla Limited has announced that its wholly-owned UKsubsidiary, Cipla (EU) Limited has signed definitive agreements for equityinvestment of...
Cipla expects elevated capital expenditure on automation to continue for three more years Ruchika Sharma27 Dec 2022 5:31 PM ISTMumbai: Cipla expects elevated capital expenditure on automation to continue for three more years, a senior official has said. The city-headquartered...
Cipla unveils Leuprolide Acetate Injection Depot for advanced prostate cancer in US Ruchika Sharma29 Nov 2022 1:00 PM ISTMumbai: Pharma major Cipla Limited and its wholly owned subsidiary Cipla USA Inc., today announced the launch of Leuprolide Acetate Injection Depot ...
Cipla gets USFDA OAI status for Goa facility Ruchika Sharma24 Nov 2022 1:30 PM ISTMumbai: Pharma major Cipla has announced that the company has received a communication from the US Food and Drug Administration (USFDA) that the...
